Skip to content

Clinical trials

Neurodevelopmental Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodevelopmental Disorders Country / region: United States Clear all

91 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20051
20062
20072
20082
20101
20111
20123
20132
20143
20151
20164
20176
20185
20193
20204
20219
20227
20239
202410
20256
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting24
Active, not recruiting13
Unknown status7
Enrolling by invitation4
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)5
University of North Carolina, Chapel Hill4
Washington University School of Medicine4
Baylor College of Medicine3
Children's Hospital Medical Center, Cincinnati3
Health Resources and Services Administration (HRSA)3
Longboard Pharmaceuticals3
Montefiore Medical Center3
Taysha Gene Therapies, Inc.3
Auburn University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodevelopmental Disorders91
Autism Spectrum Disorder21
Autistic Disorder18
Attention Deficit Disorder with Hyperactivity9
Mental Disorders9
Nervous System Diseases9
Intellectual Disability8
Epilepsy6
Genetic Diseases, Inborn6
Learning Disabilities6

Trials

Showing 26 to 50 of 91. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.